Skip to navigation Skip to main content

New Indication: Xywav

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

Xywav is now approved for the treatment of idiopathic hypersomnia in adults.

Learn more about this new indication with our slideshow, complete drug monograph, and downloadable PDF.

Topics:

Drug Slideshow First Look Hypersomnolence Disorder Sleep Disorders